JPMorgan's scale and diversified earnings power support a premium valuation, but the current price embeds that strength after EPS growth to $20.05 in 2025 and a P/E of 14.5x, a 22% premium to peers. Heavy insider selling in April 2026, including $40 million by CEO Dimon, signals caution from management, offsetting the recent smart-money buying surge. The stock is fairly valued and better held for income than bought aggressively.
Economic downturn
A recession could lift credit costs across JPM's $50 billion private credit book and consumer/corporate loan portfolios, compressing net income.
Sustained insider selling
Continued large dispositions by top executives at current levels would reinforce a negative internal view and cap upside.
Regulatory/policy shifts
Stricter capital requirements or trading restrictions could erode returns in Corporate & Investment Bank and Asset & Wealth Management.
Private credit stress
Limiting of withdrawals from non-traded BDCs, as noted in press, may signal broader private-market stress that could spill over to JPM's exposures.